Marker Therapeutics (MRKR) Short Interest Ratio & Short Volume → This is the best new way to score with AI (From Weiss Ratings) (Ad) Free MRKR Stock Alerts $4.19 +0.02 (+0.48%) (As of 12:49 PM ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaSustainability Marker Therapeutics Short Interest DataCurrent Short Volume53,900 sharesPrevious Short Volume64,400 sharesChange Vs. Previous Month-16.30%Dollar Volume Sold Short$218,295.00Short Interest Ratio / Days to Cover3.0Last Record DateApril 30, 2024Outstanding Shares8,910,000 sharesFloat Size6,440,000 sharesShort Percent of Float0.84%Today's Trading Volume2,954 sharesAverage Trading Volume18,962 sharesToday's Volume Vs. Average16% Short Selling Marker Therapeutics ? Sign up to receive the latest short interest report for Marker Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatMRKR Short Interest Over TimeMRKR Days to Cover Over TimeMRKR Percentage of Float Shorted Over Time Ad Banyan Hill PublishingForget the “Magnificent 7” Tech Companies, Buy This AI Stock InsteadThe AI boom continues to snowball with no signs of slowing... Google CEO, Sundar Pichai, made waves during a recent call with analysts, reminding them that the search engine company has been “AI first” since 2016.Get the full story here. Marker Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/202453,900 shares $218,295.00 -16.3%0.8%3 $4.05 4/15/202464,400 shares $285,936.00 -40.3%1.0%3.4 $4.44 3/31/2024107,900 shares $463,970.00 -27.9%1.7%5.1 $4.30 3/15/2024149,700 shares $663,171.00 -7.0%2.3%6 $4.43 2/29/2024160,900 shares $584,067.00 -9.6%2.5%2 $3.63 2/15/2024177,900 shares $752,517.00 +1.1%2.8%2.2 $4.23 Get the Latest News and Ratings for MRKR and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Marker Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 1/31/2024175,900 shares $816,176.00 -12.7%2.7%2.2 $4.64 1/15/2024201,400 shares $970,748.00 -14.5%3.1%2.5 $4.82 12/31/2023235,500 shares $1.30 million -10.9%3.7%2.9 $5.50 12/15/2023264,300 shares $1.24 million +56.0%4.1%3.3 $4.70 11/30/2023169,400 shares $467,544.00 -18.1%2.7%2.3 $2.76 11/15/2023206,900 shares $577,251.00 -3.9%3.2%5.6 $2.79 10/31/2023215,200 shares $516,480.00 -7.8%3.4%4.6 $2.40 10/15/2023233,400 shares $772,554.00 -10.0%3.7%2.7 $3.31 9/30/2023259,200 shares $1.18 million -16.5%4.1%2.2 $4.54 9/15/2023310,300 shares $1.66 million +65.8%4.9%2.2 $5.36 8/31/2023187,200 shares $1.05 million -11.3%3.0%0.9 $5.62 8/15/2023211,000 shares $1.24 million -23.1%3.3%0.3 $5.86 7/31/2023274,200 shares $1.38 million +43.3%4.4%0.3 $5.05 7/15/2023191,300 shares $1.01 million -41.1%3.0%0.2 $5.26 6/30/2023325,000 shares $1.01 million -28.8%5.2%0.4 $3.10 6/15/2023456,500 shares $1.13 million +478.6%7.2%0.6 $2.48 5/31/202378,900 shares $140,442.00 -26.3%1.3%0.1 $1.78 5/15/2023107,000 shares $146,590.00 -51.0%1.7%0.8 $1.37 4/30/2023218,400 shares $183,761.76 +1,169.8%3.0%1.6 $0.84 4/15/202317,200 shares $18,920.00 +91.1%0.2%0.2 $1.10 3/31/20239,000 shares $6,390.00 -90.0%0.1%0.2 $0.71 3/15/202389,900 shares $178,002.00 +37.5%1.2%1.7 $1.98 2/28/202365,400 shares $141,918.00 +64.3%0.9%1.7 $2.17 2/15/202339,800 shares $89,948.00 -18.3%0.6%1 $2.26 1/31/202348,700 shares $136,360.00 -93.7%0.8%1.2 $2.80 1/15/2023767,400 shares $272,503.74 +30.8%1.2%2.6 $0.36 12/30/2022586,600 shares $155,976.35 -21.4%1.0%1.9 $0.27 12/15/2022745,800 shares $222,621.30 -11.6%1.3%2.7 $0.30 11/30/2022843,800 shares $253,140.00 -14.7%1.4%2.5 $0.30 11/15/2022989,100 shares $343,514.43 -16.9%1.7%2 $0.35 10/31/20221,190,000 shares $528,003.00 +21.5%2.0%2.2 $0.44 10/15/2022979,200 shares $381,888.00 -16.3%1.7%0.5 $0.39 9/30/20221,170,000 shares $431,496.00 -6.4%4.3%0.6 $0.37 9/15/20221,250,000 shares $573,125.00 -9.4%4.6%0.6 $0.46Trump’s “Tax Free” Retirement Strategy (Ad)Since 1924 — over one hundred years — the US dollar has lost nearly 18x its value. In other words, a dollar back then would buy $17.82 worth of goods in today's money. If you're planning on retiring any time soon…This poses a real problem.Protect your retirement savings from the inevitable devaluation of the dollar… MRKR Short Interest - Frequently Asked Questions What is Marker Therapeutics' current short interest? Short interest is the volume of Marker Therapeutics shares that have been sold short but have not yet been closed out or covered. As of April 30th, traders have sold 53,900 shares of MRKR short. 0.84% of Marker Therapeutics' shares are currently sold short. Learn More on Marker Therapeutics' current short interest. What is a good short interest ratio for Marker Therapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. MRKR shares currently have a short interest ratio of 3.0. Learn More on Marker Therapeutics's short interest ratio. What is a good short interest percentage for Marker Therapeutics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.84% of Marker Therapeutics' floating shares are currently sold short. Is Marker Therapeutics' short interest increasing or decreasing? Marker Therapeutics saw a decrease in short interest in April. As of April 30th, there was short interest totaling 53,900 shares, a decrease of 16.3% from the previous total of 64,400 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Marker Therapeutics' float size? Marker Therapeutics currently has issued a total of 8,910,000 shares. Some of Marker Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Marker Therapeutics currently has a public float of 6,440,000 shares. How does Marker Therapeutics' short interest compare to its competitors? 0.84% of Marker Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Marker Therapeutics: ProMIS Neurosciences, Inc. (0.05%), Sensei Biotherapeutics, Inc. (0.37%), Spruce Biosciences, Inc. (0.97%), Fortress Biotech, Inc. (12.69%), BriaCell Therapeutics Corp. (4.76%), NRx Pharmaceuticals, Inc. (6.36%), Cara Therapeutics, Inc. (5.62%), Lexaria Bioscience Corp. (2.29%), Acurx Pharmaceuticals, Inc. (4.67%), Xilio Therapeutics, Inc. (5.24%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks. What does it mean to sell short Marker Therapeutics stock? Short selling MRKR is an investing strategy that aims to generate trading profit from Marker Therapeutics as its price is falling. MRKR shares are trading up $0.05 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Marker Therapeutics? A short squeeze for Marker Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of MRKR, which in turn drives the price of the stock up even further. How often is Marker Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including MRKR, twice per month. The most recent reporting period available is April, 30 2024. More Short Interest Resources from MarketBeat Related Companies: PMN Short Squeeze SNSE Short Squeeze SPRB Short Squeeze FBIO Short Squeeze BCTX Short Squeeze NRXP Short Squeeze CARA Short Squeeze LEXX Short Squeeze ACXP Short Squeeze XLO Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:MRKR) was last updated on 5/16/2024 by MarketBeat.com Staff From Our PartnersHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportBiden to Drop BOMBSHELL June 13th?Paradigm PressRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Priority GoldElon to Transform U.S. Economy? Porter & CompanyCharles Payne Demystifies OptionsUnstoppable ProsperityThe most important AI company you've never heard ofManward PressThe #1 Biotech Stock to Watch in 2024 is Attacking Viruses in a Unique WaySmallcaps DailyWATCH: The Truth About InflationBirch Gold